Page 3 - மேற்பரப்பு புற்றுநோயியல் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மேற்பரப்பு புற்றுநோயியல் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மேற்பரப்பு புற்றுநோயியல் இன்க் Today - Breaking & Trending Today

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Adamas Pharmaceuticals (NASDAQ:ADMS) - The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Adamas Pharmaceuticals (NASDAQ:ADMS) - The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

South Africa , Eastern Cape , Western Cape , Vaccinex Activmab , Clovis Oncology Inc , Oncolytics Biotech Inc , Esperion Therapeutics Inc , Xencor Inc , Aridis Pharmaceuticals Inc , Jazz Pharmaceuticals , Epizyme Inc , Immucell Corporation , Halozyme Therapeutics Inc , Masimo Corporation , Systems Inc , Rubius Therapeutics Inc , Frequency Therapeutics Inc , Revance Therapeutics Inc , Adamas Pharmaceuticals Inc , Penumbra Inc , Protalix Biotherapeutics Inc , Arena Pharmaceuticals Inc , Vaccinex Inc , Macrogenics Inc , Theravance Biopharma Inc , Insulet Corporation ,

Surface Oncology Inks SRF813 Licensing Deal With GSK For $85 Mln Upfront

Surface Oncology Inks SRF813 Licensing Deal With GSK For $85 Mln Upfront
LONDON (dpa-AFX) - Surface Oncology Inc. (SURF), a clinical-stage immuno-oncology company, said Thursday it has entered into an agreement for GlaxoSmithKline Plc. (GSK.L, GSK) to exclusively license worldwide development and commercial rights to Surface Oncology s preclinical program SRF813.
SRF813 is a fully human IgG1 antibody targeting PVRIG (also known as CD112R), an inhibitory protein expressed on natural killer cells (NK cells) and T cells. SRF813 is currently in IND-enabling studies with an IND planned for 2021.
Under the terms of the deal, GSK will make an upfront payment of $85 million. In addition, Surface Oncology may receive up to an additional $730 million in future milestone payments and will also be eligible to receive tiered royalties on global net sales. ....

City Of , United Kingdom , Glaxosmithkline Plc , Surface Oncology Inc , Surface Oncology , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , கிளாக்சோஸ்மித்க்லைன் ப்ல் , மேற்பரப்பு புற்றுநோயியல் இன்க் , மேற்பரப்பு புற்றுநோயியல் ,

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABBV) - The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABBV) - The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Biocardia Cardi , Robert Postma Jaime Vieser , Holger Weis , Morgan Stanley Matthew Harrison , Peter Traber , Gilead Sciences Inc , Us International Trade Commission , Vivos Therapeutics Inc , Meiragtx Holdings , Oncology Inc , European Union , Abbvie Inc , Gamida Cell Ltd , Zynerba Pharmaceuticals Inc , Olema Pharmaceuticals Inc , Aurinia Pharmaceuticals Inc , Sciences Inc , Products Advisory Committee On Dec , Macrogenics Inc , Abcellera Biologics Inc , Evolus Inc , Research Vaccines , Kinnate Biopharma Inc , Amgen Inc , Biocardia Inc , Surface Oncology Inc ,

Surface Oncology, GSK In License Agreement for Immunotherapy Program

Provided by
Dow Jones
By Michael Dabaie
Surface Oncology Inc. said it is in an agreement for GlaxoSmithKline PLC to exclusively license worldwide development and commercial rights to Surface Oncology s preclinical immunotherapy program SRF813.
SRF813 is an IgG1 antibody targeting PVRIG, an inhibitory protein expressed on natural killer cells and T cells.
Surface shares were up 7% to $10.70 premarket.
Under the deal, GSK will make an $85 million upfront payment. Surface Oncology may receive up to an additional $730 million in milestone payments and be eligible for royalties on net sales.
After the close of the GSK license agreement, with current cash and cash equivalents, Surface Oncology said it projects cash runway sufficient to fund operations through 2023. ....

Michael Dabaie , Dow Jones Company Inc , Surface Oncology Inc , Surface Oncology , Dow Jones , டோ ஜோன்ஸ் நிறுவனம் இன்க் , மேற்பரப்பு புற்றுநோயியல் இன்க் , மேற்பரப்பு புற்றுநோயியல் , டோ ஜோன்ஸ் ,

Annual Changes To The Nasdaq Biotechnology Index

Annual Changes To The Nasdaq Biotechnology Index
Date
11/12/2020
Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 21, 2020.
The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (Nasdaq®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).
The following 100 securities will be added to the Index:
EXCHANGE ....

Pliant Therapeutics Inc , Zentalis Pharmaceuticals Inc , Gritstone Oncology Inc , Poseida Therapeutics Inc , Oncology Holdings Inc , Nextcure Inc , Cortexyme Inc , Molecular Transport Inc , Phibro Animal Health Corporation , Evolus Inc , Passage Bio Inc , Constellation Pharmaceuticals Inc , Bio Techne Corp , Allovir Inc , Verastem Inc , Nantkwest Inc , Optinose Inc , Cerus Corporation , Sutro Biopharma Inc , Marinus Pharmaceuticals Inc , Kamada Ltd , Vir Biotechnology Inc , Teos Therapeutics Inc , Beam Therapeutics Inc , Annexon Inc , Ocular Therapeutix Inc ,